Indeed, the JAK/STAT signaling axis, specifically STAT3, promotes “stemness” in cancer stem cells and drives resistance to chemotherapy and radiotherapy, not only in AML, but also in other malignancies such as myxoid liposarcoma and colorectal cancer [127,128,129,130]. Here, STAT3 is linked to acute myeloid leukemia.